相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。RUbioSeq: a suite of parallelized pipelines to automate exome variation and bisulfite-seq analyses
Miriam Rubio-Camarillo et al.
BIOINFORMATICS (2013)
SPIB, a novel immunohistochemical marker for human blastic plasmacytoid dendritic cell neoplasms: characterization of its expression in major hematolymphoid neoplasms
Santiago Montes-Moreno et al.
BLOOD (2013)
Stem cell transplantation can provide durable disease control in blastic plasmacytoid dendritic cell neoplasm: a retrospective study from the European Group for Blood and Marrow Transplantation
Damien Roos-Weil et al.
BLOOD (2013)
Targeting Chromatin Readers
L. I. James et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2013)
The genomic landscape of hypodiploid acute lymphoblastic leukemia
Linda Holmfeldt et al.
NATURE GENETICS (2013)
TARGET WATCH Drugging the epigenome
Samia Burridge
NATURE REVIEWS DRUG DISCOVERY (2013)
Genomic and Epigenomic Landscapes of Adult De Novo Acute Myeloid Leukemia
Timothy J. Ley et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
IDH mutations in primary myelofibrosis predict leukemic transformation and shortened survival: clinical evidence for leukemogenic collaboration with JAK2V617F
A. Tefferi et al.
LEUKEMIA (2012)
Mutation Patterns of 16 Genes in Primary and Secondary Acute Myeloid Leukemia (AML) with Normal Cytogenetics
Marta Fernandez-Mercado et al.
PLOS ONE (2012)
The role of mutations in epigenetic regulators in myeloid malignancies
Alan H. Shih et al.
NATURE REVIEWS CANCER (2012)
Twenty-one cases of blastic plasmacytoid dendritic cell neoplasm: focus on biallelic locus 9p21.3 deletion
Marco Lucioni et al.
BLOOD (2011)
The prognostic significance of IDH2 mutations in AML depends on the location of the mutation
Claire L. Green et al.
BLOOD (2011)
TET2 and TP53 mutations are frequently observed in blastic plasmacytoid dendritic cell neoplasm
Fabrice Jardin et al.
BRITISH JOURNAL OF HAEMATOLOGY (2011)
TET2 Mutations Improve the New European LeukemiaNet Risk Classification of Acute Myeloid Leukemia: A Cancer and Leukemia Group B Study
Klaus H. Metzeler et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
Recurrent DNMT3A mutations in patients with myelodysplastic syndromes
M. J. Walter et al.
LEUKEMIA (2011)
Exome sequencing identifies somatic mutations of DNA methyltransferase gene DNMT3A in acute monocytic leukemia
Xiao-Jing Yan et al.
NATURE GENETICS (2011)
A framework for variation discovery and genotyping using next-generation DNA sequencing data
Mark A. DePristo et al.
NATURE GENETICS (2011)
Clinical Effect of Point Mutations in Myelodysplastic Syndromes
Rafael Bejar et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Deriving the consequences of genomic variants with the Ensembl API and SNP Effect Predictor
William McLaren et al.
BIOINFORMATICS (2010)
Retroviral insertional mutagenesis identifies Zeb2 activation as a novel leukemogenic collaborating event in CALM-AF10 transgenic mice
David Caudell et al.
BLOOD (2010)
The prognostic significance of IDH1 mutations in younger adult patients with acute myeloid leukemia is dependent on FLT3/ITD status
Claire L. Green et al.
BLOOD (2010)
Blastic plasmacytoid dendritic cell neoplasm: is transplantation the treatment of choice?
S. Dalle et al.
BRITISH JOURNAL OF DERMATOLOGY (2010)
Genetic Analysis of Transforming Events That Convert Chronic Myeloproliferative Neoplasms to Leukemias
Omar Abdel-Wahab et al.
CANCER RESEARCH (2010)
Novel mutations and their functional and clinical relevance in myeloproliferative neoplasms: JAK2, MPL, TET2, ASXL1, CBL, IDH and IKZF1
A. Tefferi
LEUKEMIA (2010)
DNMT3A Mutations in Acute Myeloid Leukemia.
Timothy J. Ley et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Frequent Mutations of Chromatin Remodeling Gene ARID1A in Ovarian Clear Cell Carcinoma
Sian Jones et al.
SCIENCE (2010)
Fast and accurate short read alignment with Burrows-Wheeler transform
Heng Li et al.
BIOINFORMATICS (2009)
The 2008 revision of the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia: rationale and important changes
James W. Vardiman et al.
BLOOD (2009)
TET2 mutations and their clinical correlates in polycythemia vera, essential thrombocythemia and myelofibrosis
A. Tefferi et al.
LEUKEMIA (2009)
Recurring Mutations Found by Sequencing an Acute Myeloid Leukemia Genome
Elaine R. Mardis et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
BFAST: An Alignment Tool for Large Scale Genome Resequencing
Nils Homer et al.
PLOS ONE (2009)
Novel markers of normal and neoplastic human plasmacytoid dendritic cells
Teresa Marafioti et al.
BLOOD (2008)
CD4+/CD56+ hematodermic neoplasm (blastic natural killer cell lymphoma):: Neoplastic cells express the immature dendritic cell marker BDCA-2 and produce interferon
Monika E. Pilichowska et al.
AMERICAN JOURNAL OF CLINICAL PATHOLOGY (2007)
CD56-positive haematological neoplasms of the skin: a multicentre study of the Cutaneous Lymphoma Project Group of the European Organisation for Research and Treatment of Cancer
Chalid Assaf et al.
JOURNAL OF CLINICAL PATHOLOGY (2007)
CD4+/CD56+ hematodermic tumor - The features of an evolving entity and its relationship to dendritic cells
Marco Herling et al.
AMERICAN JOURNAL OF CLINICAL PATHOLOGY (2007)
CD4(+) CD56(+) lineage-negative malignancies are rare tumors of plasmacytoid dendritic cells
KK Reichard et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2005)
What is CD4+CD56+malignancy and how should it be treated?
P Reimer et al.
BONE MARROW TRANSPLANTATION (2003)
'Agranular CD4+CD56+hematodermic neoplasm' (blastic NK-cell lymphoma) originates from a population of CD56+precursor cells related to plasmacytoid monocytes
T Petrella et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2002)
Clinical and biologic features of CD4(+)CD56(+) malignancies
J Feuillard et al.
BLOOD (2002)
Identification of a leukemic counterpart of the plasmacytoid dendritic cells
L Chaperot et al.
BLOOD (2001)
分享论文
